Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cohen, Joshua D., Li, Lu, Wang, Yuxuan, Thoburn, Christopher, Afsari, Bahman, Danilova, Ludmila, Douville, Christopher, Javed, Ammar A. +34 more·2018·Science

Cited by (1,003)

Items 201–300 of 1,003

  1. Diagnosis and prognosis of myocardial infarction on a plasmonic chip
    Wei Lin Xu, Lin Wang, Ru Zhang, Xuming Sun, Lin Huang, Haiyang Su, Xunbin Wei, Chia‐Chun Chen, Jiatao Lou, Hongjie Dai et al. · 2020 · Nature Communications
  2. Cancer driver mutations: predictions and reality
    Daria S. Ostroverkhova, Teresa M. Przytycka, Anna R. Panchenko · 2023 · Trends in Molecular Medicine
  3. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
    Nicolas Marie Guibert, Anne Pradines, Gilles Favre, Julien Mazières · 2020 · European Respiratory Review
  4. Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
    Pauline Gilson, Jean‐Louis Merlin, Alexandre Harlé · 2022 · Cancers
  5. A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
    Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, A. Eden Cruikshank, Katheryn Santos, Caroline Kikawa, Joseph B. Hiatt, Robert D. Patton, Navonil De Sarkar, Katharine Ann Collier et al. · 2022 · Nature Communications
  6. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
    Ilaria Alborelli, Daniele Generali, Philip M. Jermann, Maria Rosa Cappelletti, Giuseppina Ferrero, Bruna Scaggiante, Marina Bortul, Fabrizio Zanconati, Stefan Nicolet, Jasmin Haegele et al. · 2019 · Cell Death and Disease
  7. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma
    Meng Nie, Ke Yao, Xinsheng Zhu, Na Chen, Nan Xiao, Yi Wang, Bo Peng, LiAng Yao, Peng Li, Peng Zhang et al. · 2021 · Nature Communications
  8. Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer
    Matthew Krebs, Umberto Malapelle, Fabrice André, Luis Paz‐Ares, Martin Schüler, David Morgan Thomas, Gilad Wolf Vainer, Takayuki Yoshino, Christian Diego Rolfo · 2022 · JAMA Oncology
  9. Early detection of pancreatic cancer using DNA-based molecular approaches
    Singhi, Aatur D., Wood, Laura D. · 2021 · Nature Reviews Gastroenterology & Hepatology
  10. Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
    Ander Saenz‐Antoñanzas, Jaione Auzmendi-Iriarte, Estefanía Carrasco‐García, Leire Moreno‐Cugnon, Irune Ruiz, Jorge Villanúa, Larraitz Egaña, David Otaegui, Nicolàs Samprón, Ander Matheu · 2019 · Cancers
  11. The potential of liquid biopsy in the management of cancer patients
    Athina N. Markou, Eleni Tzanikou, Evi S. Lianidou · 2022 · Seminars in Cancer Biology
  12. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
    Christopher G. Smith, Tina Moser, Florent C. Mouliere, Johanna Field-Rayner, Matthew Eldridge, Anja Lisa Riediger, Dineika Chandrananda, Katrin Heider, Jonathan C. M. Wan, Anne Yvonne Warren et al. · 2020 · Genome Medicine
  13. A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma
    Zijian Yang, Michael Joseph Lariviere, Jina Ko, Jacob Edward Till, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Kyle Tien, Andrew A. Lin, Hanfei Shen et al. · 2020 · Clinical Cancer Research
  14. Nanozyme Sensor Array Plus Solvent-Mediated Signal Amplification Strategy for Ultrasensitive Ratiometric Fluorescence Detection of Exosomal Proteins and Cancer Identification
    Meng-Xian Liu, He Zhang, Xuewei Zhang, Shuai Chen, Yong‐Liang Yu, Jianhua Wang · 2021 · Analytical Chemistry
  15. The value of cell‐free DNA for molecular pathology
    Caitlin M. Stewart, Prachi D. Kothari, Florent C. Mouliere, Richard James Mair, Saira Somnay, Ryma Benayed, Ahmet Zehir, Britta Weigelt, Sarah‐Jane Dawson, Maria E. Arcila et al. · 2018 · The Journal of Pathology
  16. CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers
    Collin J. Tokheim, Rachel Karchin · 2019 · Cell Systems
  17. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies
    Qiang Gao, Y.P. Lin, B.S. Li, G.Q. Wang, Liang Dong, B.Y. Shen, Wenhui Lou, W.C. Wu, Dongliang Ge, Qian Zhu et al. · 2023 · Annals of Oncology
  18. Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer
    Joshua Moss, Aviad Zick, Albert Grinshpun, Einat Carmon, Myriam Maoz, Bracha Lea Ochana, OBAYOMI Adesoji Abraham, O. Arieli, Lili Germansky, K. Meir et al. · 2020 · Annals of Oncology
  19. Metabolic Fingerprinting on Synthetic Alloys for Medulloblastoma Diagnosis and Radiotherapy Evaluation
    Jing Cao, Xuejiao Shi, Deepanjali Dattatray Gurav, Lin Huang, Haiyang Su, Keke Li, Jingyang Niu, M. Zhang, Qian Wang, Mawei Jiang et al. · 2020 · Advanced Materials
  20. Circulating DNA fragmentomics and cancer screening
    Alain Roger Thierry · 2023 · Cell Genomics
  21. Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
    Sivapalan, Lavanya, Murray, Joseph C, Canzoniero, Jenna VanLiere, Landon, Blair, Jackson, Jennifer, Scott, Susan, Lam, Vincent, Levy, Benjamin P., Sausen, Mark, Anagnostou, Valsamo · 2023 · Journal for ImmunoTherapy of Cancer
  22. Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
    Chun‐Hao Huang, Ko-Chuan Lee, Jennifer A. Doudna · 2018 · Trends in cancer
  23. Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT
    Bifei Li, Weiyu Shen, Huayi Peng, Yumei Li, Fan Chen, Liping Zheng, Jianhua Xu, Lee Jia · 2019 · OncoTargets and Therapy
  24. KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
    Tony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M. Kerr, Myung‐Ju Ahn, Joshua R. Kapp, Fernando Augusto Soares, Yasushi Yatabe · 2023 · Lung Cancer
  25. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
    Brandon M. Lehrich, Josephine Zhang, Satdarshan P. Monga, Renumathy Dhanasekaran · 2023 · Journal of Hepatology
  26. Use of ctDNA in early breast cancer: analytical validity and clinical potential
    François Panet, Andri Papakonstantinou, María Borrell, Joan Vivancos, Ana P. Vivancos, Mafalda Oliveira · 2024 · npj Breast Cancer
  27. Screening and prevention of ovarian cancer
    Michail Ch. Sideris, Usha Menon, Ranjit Manchanda · 2024 · The Medical Journal of Australia
  28. Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer
    Igor Yu. Sokolov, Maxim Dokukin, Vivekanand Kalaparthi, Miloš D. Miljković, Andrew Wang, John D. Seigne, Petros D. Grivas, Eugene Demidenko · 2018 · Proceedings of the National Academy of Sciences
  29. Liquid Biopsy in Breast Cancer: A Focused Review
    Timothy Kwang Yong Tay, Puay Hoon Tan · 2020 · Archives of Pathology & Laboratory Medicine
  30. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
    Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Pete Ellis, Kirsten McLay, Giovanni Marsico, Tim Forshew, Christoph Walz, Christoph Andreas Reichel et al. · 2022 · British Journal of Cancer
  31. Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
    Aruni Ghose, Sri Vidya Niharika Gullapalli, Naila Chohan, Anita Bolina, Michele Moschetta, Elie Rassy, Stergios Boussios · 2022 · Proteomes
  32. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
    Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, Cristina Pellegrini, Federico Cucchiara, Francesca Salvianti, Silvia Galbiati · 2021 · Clinical Chemistry and Laboratory Medicine (CCLM)
  33. Blood biomarkers for differential diagnosis and early detection of pancreatic cancer
    Fawaz N. Al-Shaheri, Mohamed Saiel Saeed Alhamdani, Andrea S. Bauer, Nathalia A. Giese, Markus Wolfgang Büchler, Thilo Hackert, Jörg D. Hoheisel · 2021 · Cancer Treatment Reviews
  34. Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
    Miguel García-Pardo, Maisam Makarem, Janice J.N. Li, Deirdre Kelly, Natasha B. Leighl · 2022 · British Journal of Cancer
  35. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation
    Noemí Garcia‐Romero, Rodrigo Madurga, Gorjana Rackov, Irina Palacín-Aliana, Rocío Núñez‐Torres, Adriá Asensi-Puig, Josefa Carrión-Navarro, Susana Esteban-Rubio, Héctor Peinado, Anna González‐Neira et al. · 2019 · Journal of Translational Medicine
  36. Predicting breast cancer metastasis by using serum biomarkers and clinicopathological data with machine learning technologies
    Yi‐Ju Tseng, Chuan-En Huang, Chiao-Ni Wen, Po-Yin Lai, Min‐Hsien Wu, Yu-Chen Sun, Hsin‐Yao Wang, Jang‐Jih Lu · 2019 · International Journal of Medical Informatics
  37. Microfluidic systems for cancer diagnostics
    Jose Luis Garcia-Cordero, Sebastian J. Maerkl · 2019 · Current Opinion in Biotechnology
  38. Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
    Giuseppe Buono, Lorenzo Gerratana, Michela Bulfoni, Nicoletta Provinciali, Debora Basile, Mario Giuliano, Carla Corvaja, Grazia Arpino, Lucia Del Mastro, Sabino De Placido et al. · 2019 · Cancer Treatment Reviews
  39. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer
    Fahrmann, Johannes F, Bantis, Leonidas E, Capello, Michela, Scelo, Ghislaine, Dennison, Jennifer B, Patel, Nikul, Murage, Eunice, Vykoukal, Jody, Kundnani, Deepali L, Foretova, Lenka et al. · 2019 · JNCI: Journal of the National Cancer Institute
  40. Liquid Biopsy, ctDNA Diagnosis through NGS
    Lin Chen, Xuzhu Liu, Bingyi Zheng, Rongqin Ke, Chi‐Meng Tzeng · 2021 · Life
  41. Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
    Ellen Heitzer, Daan A. van den Broek, Marc Guillaume Denis, Paul M Hofman, Michael J.F. Hubank, Florent C. Mouliere, Luis G Paz-Ares, Ed M. D. Schuuring, Holger Sültmann, Gilad Wolf Vainer et al. · 2022 · ESMO Open
  42. Blueprint for cancer research: Critical gaps and opportunities
    Lynne W. Elmore, Susanna Fletcher Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps · 2020 · CA A Cancer Journal for Clinicians
  43. Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer
    Ping‐Hsien Tsou, Zong-Lin Lin, Yu-Chiang Pan, Hui-Chen Yang, Chien‐Jen Chang, Sheng‐Kai Liang, Yueh‐Feng Wen, Chia‐Hao Chang, Lih‐Yu Chang, Kai‐Lun Yu et al. · 2021 · Cancers
  44. Focused Ultrasound-enabled Brain Tumor Liquid Biopsy
    Lifei Zhu, Galen Cheng, Dezhuang Ye, Arash Nazeri, Yimei Yue, Weijun Liu, Xiaowei Wang, Gavin P. Dunn, Allegra A. Petti, Eric C. Leuthardt et al. · 2018 · Scientific Reports
  45. Biomarkers and Strategies for Early Detection of Ovarian Cancer
    Robert C. Bast, Zhen Lü, Chae Young Han, Karen H. Lu, Karen S. Anderson, Charles W. Drescher, Steven J. Skates · 2020 · Cancer Epidemiology Biomarkers & Prevention
  46. Gold Nanoparticle Couples with Entropy-Driven Toehold-Mediated DNA Strand Displacement Reaction on Magnetic Beads: Toward Ultrasensitive Energy-Transfer-Based Photoelectrochemical Detection of miRNA-141 in Real Blood Sample
    Nan Zhang, Xiaomei Shi, Hongqian Guo, Xiaozhi Zhao, Weiwei Zhao, Jing‐Juan Xu, Hong‐Yuan Chen · 2018 · Analytical Chemistry
  47. Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
    Joe Ibrahim, Marc Peeters, Guy Van Camp, Ken Op de Beeck · 2022 · European Journal of Cancer
  48. Controlling Gastric Cancer in a World of Heterogeneous Risk
    Robert J. Huang, Monika Laszkowska, Haejin In, Joo Ha Hwang, Meira Epplein · 2023 · Gastroenterology
  49. Single-EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer
    Scott W. Ferguson, Katherine S. Yang, Piotr J. Zelga, Andrew Scott Liss, Jonathan Carlson, Carlos Fernández del Castillo, Ralph Weissleder · 2022 · Science Advances
  50. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer
    Dhruvajyoti Roy, Maarit Tiirikainen · 2020 · Trends in cancer
  51. 2D graphene oxide–aptamer conjugate materials for cancer diagnosis
    Simranjeet Singh Sekhon, Prabhsharan Kaur, Yang‐Hoon Kim, Satpal Singh Sekhon · 2021 · npj 2D Materials and Applications
  52. The translational challenges of precision oncology
    Oriol Pich, Chris Bailey, Thomas B.K. Watkins, Simone Zaccaria, Mariam Jamal‐Hanjani, Charles Swanton · 2022 · Cancer Cell
  53. Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer
    Mary L. Stackpole, Weihua Zeng, Shuo Li, Chun-Chi Liu, Yonggang Zhou, Shanshan He, Angela Yeh, Ziye Wang, Fengzhu Sun, Qingjiao Li et al. · 2022 · Nature Communications
  54. Considerations and quality controls when analyzing cell-free tumor DNA
    Gustav Johansson, Daniel Andersson, Stefan Filges, Junrui Li, Andreas Muth, Tony E. Godfrey, Anders Ståhlberg · 2019 · Biomolecular Detection and Quantification
  55. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
    Marin Strijker, Eline C. Soer, Matteo De Pastena, Aafke Creemers, Alberto Balduzzi, Jamie J. Beagan, Olivier R. Busch, Otto M. van Delden, Hans Halfwerk, Jeanin Elise van Hooft et al. · 2019 · International Journal of Cancer
  56. Lossless enrichment of trace analytes in levitating droplets for multiphase and multiplex detection
    Xueyan Chen, Qianqian Ding, Chao Bi, Jian Ruan, Shikuan Yang · 2022 · Nature Communications
  57. A clinician’s handbook for using ctDNA throughout the patient journey
    Samantha Ourania Hasenleithner, Michael R. Speicher · 2022 · Molecular Cancer
  58. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
    James R. Black, Gabor T. Bartha, Charles W. Abbott, Sean Michael Boyle, Takahiro Karasaki, Bailiang Li, Rui Chen, Jason Harris, Selvaraju Veeriah, Martina Colopi et al. · 2025 · Nature Medicine
  59. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics
    Anubhav Srivastava, Darren J. Creek · 2018 · PROTEOMICS
  60. A Multifunctional Platinum Nanoreactor for Point-of-Care Metabolic Analysis
    Lin Huang, Deepanjali Dattatray Gurav, Shu‐Pao Wu, Wei Lin Xu, Vadanasundari Vedarethinam, Jing Yang, Haiyang Su, Xinze Wan, Yuan Fang, Baiyong Shen et al. · 2019 · Matter
  61. Opto-Thermophoretic Manipulation
    Shaofeng Liu, Linhan Lin, Hong‐Bo Sun · 2021 · ACS Nano
  62. Novel biomarkers for early detection of gastric cancer
    Tasuku Matsuoka, Masakazu Yashiro · 2023 · World Journal of Gastroenterology
  63. Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer
    Kelly Cristina da Silva Oliveira, Iago Barroso Ramos, Jéssica Manoelli Costa da Silva, Williams Fernandes Barra, Gregory Joseph Riggins, Vikrant Palande, Catarina Torres Pinho, Milana Frenkel‐Morgenstern, Sidney Santos, Paulo Pimentel de Assumpção et al. · 2020 · Molecular Cancer Research
  64. Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
    Jonathan Dao, Patrick Conway, Baskaran Subramani, Devi Meyyappan, Sammy Russell, Daruka Mahadevan · 2023 · International Journal of Molecular Sciences
  65. Single extracellular vesicle analysis for early cancer detection
    Scott W. Ferguson, Katherine S. Yang, Ralph Weissleder · 2022 · Trends in Molecular Medicine
  66. A Review of Advanced Multifunctional Magnetic Nanostructures for Cancer Diagnosis and Therapy Integrated into an Artificial Intelligence Approach
    G. Bharath, Muhammad Ashraf Sabri, Abdul Hai, FAWZI A. BANAT, Mohammad Abu Haija · 2023 · Pharmaceutics
  67. A sustainable approach to universal metabolic cancer diagnosis
    Ruimin Wang, Shouzhi Yang, Mengfei Wang, Yan Zhou, Xvelian Li, Wei Chen, Wanshan Liu, Yida Huang, Jiao Wu, Jing Cao et al. · 2024 · Nature Sustainability
  68. Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
    Marta Tellez-Gabriel, Erik Knutsen, Maria Perander · 2020 · International Journal of Molecular Sciences
  69. The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
    Cláudia Freitas, Catarina Sousa, Francisco Machado, Mariana Serino, Vanessa Santos, Natália Alves Martins, Armando Teixeira, António Manuel Trigueiros da Silva Cunha, Tânia Pereira, Hélder P. Oliveira et al. · 2021 · Frontiers in Oncology
  70. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
    Lincoln D. Nadauld, Charles H. McDonnell, Tomasz M. Beer, MC Liu, Eric A. Klein, Andrew G. Hudnut, Richard Whittington, Bruce Taylor, Geoffrey R. Oxnard, Jafi Alyssa Lipson et al. · 2021 · Cancers
  71. Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
    Tiago Brito‐Rocha, Vera Constâncio, Rui Henrique, Cármen Jerónimo · 2023 · Cells
  72. Advances in liquid biopsy approaches for early detection and monitoring of cancer
    Babayan, Anna, Pantel, Klaus · 2018 · Genome Medicine
  73. Simultaneous Quantification of Multiple Cancer Biomarkers in Blood Samples through DNA‐Assisted Nanopore Sensing
    Lei Liu, Ting Li, Shouwen Zhang, Song Peng, Bingyuan Guo, Yuliang Zhao, Hai‐Chen Wu · 2018 · Angewandte Chemie International Edition
  74. Selenium-Containing Nanomaterials for Cancer Treatment
    Tianyu Li, Huaping Xu · 2020 · Cell Reports Physical Science
  75. Role of ctDNA in Breast Cancer
    Marta Sant, Adrià Bernat‐Peguera, Eudald Felip, Mireia Margelí Vila · 2022 · Cancers
  76. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
    Luc Cabel, Emmanuelle Jeannot, Ivan Bièche, Sophie Vacher, Céline Callens, Louis Bazire, Adeline Morel, Alice Bernard‐Tessier, Walid Chemlali, Anne Schnitzler et al. · 2018 · Clinical Cancer Research
  77. Machine learning algorithms enhance the specificity of cancer biomarker detection using SERS-based immunoassays in microfluidic chips
    Nariman Banaei, Javad Moshfegh, Arman Mohseni-Kabir, Jean Marie Houghton, Yubing Sun, Byung Gon Kim · 2019 · RSC Advances
  78. The biological functions and clinical applications of exosomes in lung cancer
    Rui Chen, Xin Xu, Zijun Qian, Congcong Zhang, Yongjie Niu, Zhixian Wang, Jianli Sun, Xiao Zhang, Yongchun Yu · 2019 · Cellular and Molecular Life Sciences
  79. Recent advances in waste-recycled nanomaterials for biomedical applications: Waste-to-wealth
    M. Abd Elkodous, Hussein M. El‐Husseiny, Gharieb Saied El-Sayyad, Amr Hosny Hashem, Ahmed Soliman Doghish, Dounia Elfadil, Yasmine Radwan, Hayam M. El-Zeiny, Heba Bedair, Osama A. Ikhdair et al. · 2021 · Nanotechnology Reviews
  80. Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
    Gianluca Mauri, Pietro Paolo Vitiello, Alberto Sogari, Giovanni Crisafulli, Andrea Sartore Bianchi, Silvia Marsoni, Salvatore Siena, Alberto Bardelli · 2022 · British Journal of Cancer
  81. Biomolecular Sensing at the Interface between Chiral Metasurfaces and Hyperbolic Metamaterials
    Giovanna Palermo, Giuseppe Emanuele Lio, Marco Esposito, Loredana Ricciardi, Mariachiara Manoccio, Vittorianna Tasco, A. Passaseo, Antonio De Luca, Giuseppe Strangi · 2020 · ACS Applied Materials & Interfaces
  82. New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening
    Allan K. Hackshaw, Christina A. Clarke, Anne‐Renee Hartman · 2022 · Cancer Cell
  83. Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens
    Connie Claire Qiu, Roberto Caricchio, Stefania Gallucci · 2019 · Frontiers in Immunology
  84. Metasurface‐Enhanced Lab‐on‐Fiber Biosensors
    Marco Consales, Giuseppe Quero, Sara Spaziani, Maria Principe, Alberto Micco, Vincenzo Galdi, Antonello Cutolo, Andrea Cusano · 2020 · Laser & Photonics Review
  85. CRISPR/Cas-Based In Vitro Diagnostic Platforms for Cancer Biomarker Detection
    Shaohua Gong, Shiqi Zhang, Fei Lü, Wei Pan, Na Li, Bo Tang · 2021 · Analytical Chemistry
  86. Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
    Wen, Xiaosha, Pu, Huijie, Liu, Quan, Guo, Zifen, Luo, Dixian · 2022 · Cancers
  87. Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue
    Jared Ostmeyer, Scott Christley, Inimary T. Toby, Lindsay Grey Cowell · 2019 · Cancer Research
  88. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression
    Lei Chang, Jie Ni, Ying Zhu, Bairen Pang, Peter Graham, Hao Zhang, Yong Li · 2019 · Theranostics
  89. De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection
    Daria Beshnova, Jianfeng Ye, Oreoluwa Onabolu, Benjamin Moon, Wenxin Zheng, Yang‐Xin Fu, James Brugarolas, Jayanthi Sivasothy Lea, Bo Li · 2020 · Science Translational Medicine
  90. Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN
    Katherine S. Yang, Debora Ciprani, Aileen O’Shea, Andrew Scott Liss, Robert Yang, Sarah Fletcher-Mercaldo, Mari A. Mino-Kenudson, Carlos F. Fernandez-del Castillo, Ralph Weissleder · 2020 · Gastroenterology
  91. Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
    Jacob J. Adashek, Filip Jankú, Razelle Kurzrock · 2021 · Cancers
  92. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
    Yoshiyuki Yamamoto, Motohide Uemura, Masashi Fujita, Kazuhiro Maejima, Yoko Koh, Makoto Matsushita, Kosuke Nakano, Yujiro Hayashi, Cong Wang, Yu Ishizuya et al. · 2018 · Cancer Science
  93. Optimizing Precision Medicine for Public Health
    Gemma A. Bilkey, Belinda L. Burns, Emily P. Coles, Trinity Mahede, Gareth S Baynam, Kristen J. Nowak · 2019 · Frontiers in Public Health
  94. Challenges and achievements of liquid biopsy technologies employed in early breast cancer
    Alfonso Alba-Bernal, Rocío Lavado-Valenzuela, María Emilia Domínguez-Recio, Begoña Jiménez-Rodríguez, María Isabel Queipo‐Ortuño, Emilio Alba, Iñaki Comino‐Méndez · 2020 · EBioMedicine
  95. Cell-free DNA TAPS provides multimodal information for early cancer detection
    Paulina Siejka-Zielińska, Jingfei Cheng, Felix Jackson, Yibin Liu, Zahir F. Soonawalla, Srikanth Reddy, Michael Silva, Luminita Puta, Misti Vanette McCain, Emma Louise Culver et al. · 2021 · Science Advances
  96. Circulating Tumor DNA in Lymphoma: Principles and Future Directions
    Mark J. Roschewski, Davide Rossi, David Matthew Kurtz, Ash A. Alizadeh, Wyndham Hopkins Wilson · 2021 · Blood Cancer Discovery
  97. Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’
    Alicia‐Marie Conway, Claire L. Mitchell, Elaine Kilgour, Gerard Brady, Caroline Dive, Natalie Cook · 2018 · British Journal of Cancer
  98. Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology
    Sandip Kumar Patel, Bhawana George, Vineeta Rai · 2020 · Frontiers in Pharmacology
  99. Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy
    María José Serrano, M. Carmen Garrido-Navas, Juan J. Díaz‐Mochon, Massimo Cristofanilli, Ignacio Gil Bazo, Patrick Pauwels, Umberto Malapelle, Alessandro Russo, Jose Antonio Lorente, Antonio José Ruiz-Rodríguez et al. · 2020 · Cancer Discovery
  100. Improving outcomes in patients with oesophageal cancer
    Manish A. Shah, Nasser Khaled Altorki, Pretish Patel, Sebron W. Harrison, Adam Joel Bass, Julian A. Abrams · 2023 · Nature Reviews Clinical Oncology